Cargando…

Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma

BACKGROUND: The non-classical human leukocyte antigen (HLA)-G is a strong immunomodulatory molecule. Under physiological conditions, HLA-G induces immunological tolerance in immune privileged tissues, while under pathophysiological situations it contributes to immune escape mechanisms. Therefore, HL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedrich, Michael, Stoehr, Christine, Jasinski-Bergner, Simon, Hartmann, Arndt, Wach, Sven, Wullich, Bernd, Steven, André, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526213/ https://www.ncbi.nlm.nih.gov/pubmed/32993793 http://dx.doi.org/10.1186/s12967-020-02544-0

Ejemplares similares

HLA-E expression and its clinical relevance in human renal cell carcinoma
por: Seliger, Barbara, et al.
Publicado: (2016)

CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma
por: Friedrich, Michael, et al.
Publicado: (2020)

Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2016)

Role of miRs in immune suppression
por: Seliger, Barbara, et al.
Publicado: (2014)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019)

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
por: Kahlmeyer, Andreas, et al.
Publicado: (2019)

Endogenous Retroviral–K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma
por: Weyerer, Veronika, et al.
Publicado: (2021)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
por: Keck, Bastian, et al.
Publicado: (2013)

HLA-G-specific microRNAs a novel approach for targeting tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2013)

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort
por: Weyerer, Veronika, et al.
Publicado: (2021)

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma
por: Tretbar, Sandy, et al.
Publicado: (2019)

Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients
por: Stöhr, Christine G., et al.
Publicado: (2019)

Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
por: Bellut, Julia, et al.
Publicado: (2017)

What turns CREB on? And off? And why does it matter?
por: Steven, André, et al.
Publicado: (2020)

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation
por: Quandt, Dagmar, et al.
Publicado: (2014)

Molecular mechanisms of human herpes viruses inferring with host immune surveillance
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
por: Stoehr, Christine G., et al.
Publicado: (2012)

Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target
por: Steven, André, et al.
Publicado: (2016)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Role of HLA-G in Viral Infections
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study
por: Rogler, Anja, et al.
Publicado: (2014)

Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors
por: Marquardt, Alexander, et al.
Publicado: (2022)

TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
por: Weyerer, Veronika, et al.
Publicado: (2021)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes
por: Wach, Sven, et al.
Publicado: (2019)

The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression
por: Protze, Johanna, et al.
Publicado: (2022)

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
por: Seliger, Barbara, et al.
Publicado: (2022)

Linking CREB function with altered metabolism in murine fibroblast-based model cell lines
por: Steven, André, et al.
Publicado: (2017)

Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
por: Eckstein, Markus, et al.
Publicado: (2018)

Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization
por: Steven, André, et al.
Publicado: (2016)

Impact of the body mass index on perioperative immunological disturbances in patients with hip and knee arthroplasty
por: Jasinski-Bergner, Simon, et al.
Publicado: (2017)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
por: Sikic, Danijel, et al.
Publicado: (2017)

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
por: Kubon, Jennifer, et al.
Publicado: (2020)

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients
por: Lazaridou, Maria-Filothei, et al.
Publicado: (2020)

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
por: Eckstein, Markus, et al.
Publicado: (2018)

“Tumor immunology meets oncology (TIMO) XV”, April 25th–27th 2019, Halle/Saale, Germany
por: Steven, André, et al.
Publicado: (2020)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_me2jga849saqud4gt86m4rmaqc